Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Upender Kapoor

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Indian Journal of Pediatrics|January 15, 2004
Plasma cortisol levels in acute asthmaUpender Kapoor, Girish Tayal, S K Mittal, et al.
The European Respiratory Journal|April 29, 2022
Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL<sup>-1</sup>Klaus F Rabe, Ian D Pavord, Mario Castro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2021
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory StudiesBob Geng, Claus Bachert, William W Busse, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 31, 2022
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic EsophagitisMichael E Wechsler, Amy D Klion, Pierluigi Paggiaro, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccinesMichael E Wechsler, Adelmir Souza-Machado, Christine Xu, et al.
The New England Journal of Medicine|December 8, 2021
Dupilumab in Children with Uncontrolled Moderate-to-Severe AsthmaLeonard B Bacharier, Jorge F Maspero, Constance H Katelaris, et al.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Indian Journal of Pediatrics|January 15, 2004
Plasma cortisol levels in acute asthmaUpender Kapoor, Girish Tayal, S K Mittal, et al.
The European Respiratory Journal|April 29, 2022
Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL<sup>-1</sup>Klaus F Rabe, Ian D Pavord, Mario Castro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2021
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory StudiesBob Geng, Claus Bachert, William W Busse, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 31, 2022
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic EsophagitisMichael E Wechsler, Amy D Klion, Pierluigi Paggiaro, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccinesMichael E Wechsler, Adelmir Souza-Machado, Christine Xu, et al.
The New England Journal of Medicine|December 8, 2021
Dupilumab in Children with Uncontrolled Moderate-to-Severe AsthmaLeonard B Bacharier, Jorge F Maspero, Constance H Katelaris, et al.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
Pageof 1